Oral Abstracts – Oncological and Functional Outcomes Post Focal Low-Dose-Rate Brachytherapy for Low-Intermediate Risk Prostate Cancer – Results from Australia’s LIBERATE Registry
Mohammadmehdi Adhami offers a detailed exploration of focal brachytherapy outcomes for low to intermediate-risk prostate cancer. In this 6-minute presentation, Adhami analyzes the LIBERATE registry, a clinical register tracking 120 men undergoing focal low-dose-rate brachytherapy.
Adhami first highlights functional outcomes, with urinary, bowel, and erectile functions showing only mild initial impairment. The discussion then transitions to interpreting prostate-specific antigen (PSA) levels post-treatment.
Read More